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Background Carcinogen-inflicted human cancers, including lung
tumours harbour thousands of mutations per genome, most of
which are unknown (Garraway, LA et al, Cell 2013;153:17–37).
Aim To develop a faithful mouse model of human tobacco carci-
nogen-induced lung adenocarcinoma suitable for the identifica-
tion of novel oncogenic genes and pathways.
Methods We repeatedly managed to obtain several murine lung
adenocarcinoma cell lines (MLA) by chronically exposing various
mouse strains to different tobacco carcinogens. MLA were char-
acterised for cancer stemness and oncogenes, as well as global
gene expression.
Results To date, 12 MLA cell lines have been derived from Wt
and transgenic mice on the FVB, Balb/c, and C57BL/6 strains by
means of urethane or diethylnitrosamine exposure. All MLA
were immortal, phenotypically stable, and indefinitely passaged
in vitro over a period of over 18 months and/or 60 passages. In
addition, all cell lines were oncogenic, transplantable, metastatic,
and uniformly lethal in vivo. Interestingly, MLA displayed Kras
mutations in codon 61, mono- or bi-allelic Trp53 loss, and
expression of lung cancer stemness factors Itgb3 and Lgr6, in
amazing similarity to human lung cancers. Microarray revealed
that all MLA cell lines heavily overexpressed Prl2c2, encoding
proliferin, in comparison to the native lungs. Prl2c2 silencing
diminished MLA proliferation and stemness, to a degree compa-
rable with Itgb3 interference.
Conclusions MLA are faithful models of human lung adenocarci-
noma that led to the discovery of Prl2c2 as a candidate lung
tumour promoter.
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Osteopontin (secreted phosphoprotein 1; SPP1) expression has
been identified in human lung cancer and has been linked with
enhanced tumour progression. To examine its functional role, we
induced lung tumours by repetitive urethane or MCA/BHT lung
carcinogens in C57BL/6 mice lacking both (Spp1-/-), one (Spp1
+/-), or no (Spp1+/+) copy of the endogenous Spp1 gene. Pri-
mary end-points were lung tumour number and size; secondary
end-points were SPP1 expression, epithelial cell survival, carcino-
gen-induced inflammation, and angiogenesis. Data are presented
as mean ± SD.
Compared with Spp1+/+ mice (n = 22), Spp1-/- mice
(n = 25) developed dramatically fewer and significantly smaller
lung tumours in response to urethane, while Spp1± mice
(n = 12) behaved similar to Spp1-/- mice (number/diameter of
lung tumours in Spp1+/+, Spp1+/-, and Spp1-/- mice, respec-
tively: 16.1 ± 12.7/1.2 ± 0.3 mm, 2.4 ± 2.3/0.9 ± 0.2 mm, and
1.3 ± 1.6/0.7 ± 0.2 mm; P < 0.05 for comparison of Spp1+/+
with Spp1-/- and Spp1+/- mice). Spp1-/- mice were also protected
from two-hit MCA/BHT-oncogenesis compared with Spp1+/+
controls. Spp1-/- mice displayed decreased epithelial cell survival
and reduced numbers of airspace macrophages early after ure-
thane, and enhanced tumour cell apoptosis and limited tumour
angiogenesis at late stages of lung tumour progression. SPP1 was
expressed in the naïve lung by non-ciliated airway epithelial cells
and alveolar macrophages and was significantly up-regulated dur-
ing multi-stage lung carcinogenesis.
Our data indicate that SPP1 is functionally involved in airway
epithelial carcinogenesis and may present a target for lung cancer
treatment and prevention.
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Background Aberrations of EGFR signalling drive cancer devel-
opment. In squamous cell lung cancer (SqCLC), EGFR is overex-
pressed. LRIG1 is a negative regulator of EGFR and patient pre-
invasive SqCLC samples show LRIG1 loss, suggesting involve-
ment in early disease pathogenesis. In skin and gut homeostasis,
LRIG1 regulates stem cells. In the upper airway, basal cells act as
stem cells and are the putative origin of SqCLC. We hypothesise
LRIG1 has a key role in airway homeostasis and its loss promotes
pre-invasive SqCLC development.
Methods Lrig1 EGFP-ires-CreERT2 mice were used to delineate
airway LRIG1 expression. Flow sorted LRIG1-positive and -nega-
tive murine basal cells were used in 2D and 3D colony-forming,
spheroid and proliferation assays. A murine SqCLC model was
set up through application of N-Nitrosotris-(2-chloroethyl)urea
(NTCU). Pre-invasive lesions and tumour development were
compared between wild-type (WT), heterozygous and LRIG1-
knockout (KO) animals. Human basal cells obtained from bron-
choscopy were sorted according to LRIG1 expression and used
directly in colony-forming assays or maintained in primary cul-
ture to assess the effect of shRNA knockdown of LRIG1. LRIG1-
knockdown cells were assessed in colony-forming and prolifera-
tion assays, and differentiation and invasion were assessed using
organotypic models.
Results LRIG1 is expressed by 40% of airway basal cells. LRIG1-
expressing murine basal cells exhibit increased colony-forming
capacity (p = 0.0286), spheroid formation (p = 0.0043) and
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